Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Cash from Financing Activities data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 76.53% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.8 million, down 63.92%, while the annual FY2025 figure was $1.8 million, 63.92% down from the prior year.
  • Cash from Financing Activities reached $1.3 million in Q4 2025 per SGHT's latest filing, up from $25000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $252.7 million in Q3 2021 and bottomed at -$942000.0 in Q1 2024.
  • Average Cash from Financing Activities over 5 years is $13.1 million, with a median of $138000.0 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 148748.24% in 2021, then crashed 503.85% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $91000.0 in 2021, then skyrocketed by 792.31% to $812000.0 in 2022, then tumbled by 53.69% to $376000.0 in 2023, then soared by 1333.24% to $5.4 million in 2024, then plummeted by 76.53% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $1.3 million in Q4 2025, $25000.0 in Q3 2025, and $485000.0 in Q2 2025.